The Murdoch Children’s Research Institute in Melbourne landed a significant federal boost and a major private pledge at its 40th anniversary gala, setting a bold course for long-term pediatric research and practical treatments that aim to change how we prevent and treat childhood illness.
The government announced a $5 million grant to kickstart a new research team focused on children’s health, unveiled in front of a packed room of experts and supporters. That announcement came alongside a high-profile private lead donation from Sarah and Lachlan Murdoch to launch the Horizon Fund. Together, these moves signal a push toward sustained funding and ambitious, population-scale projects.
“For 40 years, MCRI has been a global leader in children’s health research,” Prime Minister Anthony Albanese told the gala crowd, underscoring the institute’s international reputation. The federal money will be used to back work aimed at preventing a range of childhood conditions, from obesity and heart disease to mental health struggles and lifelong disabilities. This is the kind of targeted investment that tries to turn breakthroughs in the lab into real outcomes for families.
The Horizon Fund, seeded by the Murdochs, is being set up as a permanent endowment to support long-term research and future medical breakthroughs. Its organizers aim to raise between $50 million and $100 million in the first year, with a goal of reaching $200 million inside five years. That kind of capital is meant to protect big-picture projects from the short-term funding cycle that often interrupts promising science.
Back in 2020, the Murdoch family already contributed $5 million to create a perpetual fellowship for leading researchers working in areas like stem cell science and genomic precision medicine. MCRI’s strategy mixes immediate priorities with plans to safeguard research that needs time to mature. The institute’s model is about steady investment, not quick headlines.
Co-founded in 1986 by Dame Elisabeth Murdoch and Professor David Danks, MCRI has grown into a hub of roughly 1,800 scientists, researchers and clinicians worldwide. The institute’s founders set out with a mission that still guides them today: improving childhood health across generations. That founding vision is visible in the lab benches, clinical trials and community programs that now make up the institute’s work.
“Dame Elisabeth’s leadership, along with her values, shaped both the direction and the ethos of the Institute we were to become – for all children to live a healthy and fulfilled life,” said Sarah Murdoch, reflecting on the legacy that helped create MCRI. “With the generosity of a remarkable group of founding donors alongside the Murdoch family – Sir Jack Brockhoff, the Miller family, and The Scobie and Claire Mackinnon Trust – the foundations were laid for an Institute designed to bring our brightest minds, to serve all children, not only in that moment, but for generations to come,” Ms. Murdoch added.
“I see what is possible when foresight, science, commitment, collaboration and heartfelt generosity come together,” she emphasized. “Because behind every breakthrough is a child — a family desperate for answers. A future changed because of the commitment by so many.” Those are strong, direct reminders that funding translates into real hope for families living with rare or chronic pediatric conditions.
MCRI Director Kathryn North thanked the prime minister and highlighted the institute’s clear purpose. “From the beginning, MCRI has been guided by a simple but powerful purpose: to give all children the opportunity to live a healthy and fulfilled life,” North said. “It reflects a belief that good health is the foundation for a full life, and that opportunity should never be limited by circumstance.”
“We are harnessing the power of human stem cell technologies to grow heart patches, functional mini kidneys, blood and immune cells … to better understand disease, and to develop regenerative therapies using a patient’s own stem cells to replace organ transplants and the risk of rejection,” she said. That work aims at replacing decades of symptomatic care with curative or regenerative approaches where possible.
“These are big problems that will require significant and ongoing support,” she said. “Through our work globally, we are helping communities raise their expectations to both deliver and receive the sort of healthcare we take for granted.” “Our ambition now is to translate these partnerships into population-scale solutions that improve the lives of millions of children worldwide,” North added. “This is not simply the next chapter for MCRI – it is the work of building the future of children’s health.”
